An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

NCT05559177 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
9
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Pudong Hospital